Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise as nonsteroidal treatments for hair loss.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Dietary L-serine supplementation can reduce symptoms of HSAN1 by lowering harmful 1-deoxySL levels.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

A new, efficient method creates sulfinimidate esters from sulfenamides and alcohols without metals.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

GD-23 reduces anxiety by relying on neurosteroid production.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Compound 15a was effective in inhibiting 5α-reductase.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

A 6-year-old girl had a rare allergic reaction to a hair regrowth treatment.